
    
      This is an open-label, single-arm, phase I trial. The purpose of this study is to :

        -  Test a safe and tolerable dose of TY-302 single and the combination with Tamoxifen

        -  Determine the response rate of the combination

        -  Further evaluate the safety and side effect profile for the combination of TY-302 and
           Tamoxifen.
    
  